C Ray Therapeutics

China
Chengdu, Sichuan, China

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
3
Total equity funding
$100M
Last funding
Series A / $100M / 2024-11-16
Last equity funding
Series A / $100M
Investors
6
Lead investors
2
Articles
9

Founders and investors

Lead investors

Shenzhen Capital GroupTailong Investment

Investors

3SBio Inc.GL Ventures LLCHBM Healthcare InvestmentsShenzhen Capital GroupTailong Investment